Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Agilent, MDS Proteomics to Collaborate on Protein Analysis Technology

NEW YORK, May 22 – Signaling its effort to expand into the burgeoning proteomics arena, Agilent Technologies said Tuesday it has agreed to partner with MDS Proteomics to develop laboratory technology for identifying and analyzing proteins more quickly. 

The joint effort will draw on Agilent’s expertise in separation science and liquid chromatography, and MDS Proteomics’ experience in mass spectrometry, bioinformatics, and the study of protein pathways.

“Right now getting [separations] technology configured for proteomics has tremendous benefit for our customers, “ said Doug Forsyth, a spokesman for Agilent. 

Forsyth said Agilent and MDS will combine existing technology such as liquid chromatography and mass spectrometry with bioinformatics solutions specifically tailored for proteomics to boost the throughput of protein analysis.

“Together we’ll identify bottlenecks, problems,” said Forsyth. “Agilent will come up with the equipment, and MDS will provide certain components” such as bioinformatics expertise.

From the collaboration, the two companies hope to sell equipment and laboratory technology to pharmaceutical, biotechnology, and other companies in engaged in proteomics research. Further financial details of the collaboration were not disclosed.  
The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.